TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 80 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2014. The put-call ratio across all filers is 5.00 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $281,000 | +16.1% | 3,905 | +19.2% | 0.02% | +11.8% |
| Q1 2021 | $242,000 | -8.0% | 3,277 | -31.7% | 0.02% | 0.0% |
| Q3 2020 | $263,000 | -35.2% | 4,800 | -21.3% | 0.02% | -39.3% |
| Q2 2020 | $406,000 | -18.1% | 6,100 | -24.7% | 0.03% | -28.2% |
| Q1 2020 | $496,000 | -30.3% | 8,100 | 0.0% | 0.04% | -11.4% |
| Q4 2019 | $712,000 | -73.2% | 8,100 | -56.2% | 0.04% | -37.1% |
| Q2 2015 | $2,660,000 | +6.3% | 18,512 | +4.4% | 0.07% | +12.9% |
| Q1 2015 | $2,502,000 | +314.9% | 17,740 | +312.6% | 0.06% | +287.5% |
| Q2 2014 | $603,000 | 0.0% | 4,300 | -20.8% | 0.02% | +6.7% |
| Q1 2014 | $603,000 | +80.0% | 5,429 | +60.2% | 0.02% | -62.5% |
| Q4 2013 | $335,000 | +34.0% | 3,389 | +2.9% | 0.04% | +471.4% |
| Q3 2013 | $250,000 | -30.7% | 3,295 | -49.0% | 0.01% | -22.2% |
| Q2 2013 | $361,000 | – | 6,464 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 78,905 | $8,306,000 | 7.65% |
| FORT, L.P. | 157,584 | $16,589,000 | 4.68% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 808,200 | $85,079,000 | 4.39% |
| Strategic Global Advisors, LLC | 81,432 | $8,572,000 | 3.18% |
| Prince Street Capital Management LLC | 48,700 | $5,127,000 | 1.62% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,309,000 | 1.45% |
| Freestone Capital Holdings, LLC | 84,900 | $8,937,000 | 0.77% |
| RPG Investment Advisory, LLC | 17,227 | $1,813,000 | 0.61% |
| CLINTON GROUP INC | 46,370 | $4,881,000 | 0.28% |
| USA FINANCIAL FORMULAS | 10,786 | $1,135,000 | 0.28% |